BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Amphion Innovations plc Partner Company Supertron Acquires Spin Systems; Changing Name To m2m Imaging Corp.


11/13/2006 10:25:32 AM

LONDON & NEW YORK--(BUSINESS WIRE)--Amphion Innovations plc ("Amphion"), a developer of life sciences and technology businesses, announces today that one of its Partner Companies, Supertron Technologies ("Supertron"), a developer of high performance clinical and preclinical imaging products for magnetic resonance imaging (MRI), has acquired Spin Systems, an Australia based manufacturer of MRI coils and other imaging accessories. Following the acquisition, the enlarged company will change its name to m2m Imaging Corporation ("m2m") to encapsulate the broad spectrum of "molecule-to-man" imaging products the new combined company is developing.

Spin Systems was acquired by Superton for 313,878 Series C Preferred Shares valued at $5.00 per share and $752,284 in cash. The total consideration of the acquisition was $2,322,000.

Supertron Chief Executive Officer C. Richard Hullihen will serve as the CEO of the combined company. Amphion will be the largest strategic investor in m2m with a 23.5% percent ownership interest. The post acquisition value for m2m is $20m based on the offering price of the Series C Round, closed in July 2006.

m2m will combine Spin Systems' well-established portfolio of MRI coils and accessories with Supertron's cryogenic coil technology. The cryogenic coil has been shown to dramatically improve the performance of the MRI scanner, producing significantly clearer images in less time.

Richard C. E. Morgan, Amphion's Chief Executive Officer, said:

"m2m's evolution demonstrates the strength of Amphion's company building model. Since Supertron became one of Amphion's Partner Companies, we have developed it rapidly from a University start-up into an established, revenue producing company, with industry leading partners, strong technology and world class management.

"The cryogenic coils have the potential to provide doctors and clinicians with much needed superior imaging for earlier disease detection and faster drug development. m2m's products greatly enhance MRI imaging by reducing scan time, greatly lowering the cost and producing significantly clearer images."

About Amphion Innovations plc

Amphion Innovations plc (AMP) is listed on the AIM of the London Stock Exchange. Amphion's business activities are the formation, financing, management and development of life sciences and technology companies, working in partnership with corporations, governments, universities and entrepreneurs seeking to commercialize their intellectual property.

Website: www.amphionplc.com

About m2m Imaging Corp.

m2m Imaging is a market leading developer and manufacturer of conventional and cryogenic preclinical and clinical MRI coils and imaging accessories. Our gateway technology MRI coils have demonstrated capability of significantly increasing speed and resolution of the MRI scanner for imaging molecules to man. m2m's coils have been demonstrated at leading medical institutions such as Brigham & Women's Hospital of Harvard Medical School.

Website: www.m2mimaging.com

Contact: Amphion Innovations plc Josh Berkman, +1 646-747-7158 Media Relations or m2m Imaging Corp. Cameron Barnard, +1 862-368-3524 or Financial Dynamics Ben Atwell / John Gilbert, +44 207 269 7169

Source: Amphion Innovations plc

>>> Discuss This Story


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->